Larimar Therapeutics, Inc.
LRMRNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $245.30M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.92$6.42
- Volume (live)
- -
- Avg. volume (3M)
- 1.63M
Larimar Therapeutics (LRMR) Stock Price & Financial Analysis
Larimar Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $2.22 - $2.37 |
|---|---|
| 52-Week High | $6.42 |
| 52-Week Low | $1.92 |
| Open | $2.27 |
| Volume (last close) | 1.14M |
| Average Volume (3M) | 1.63M |
| 50-Day MA | $3.51 |
|---|---|
| 200-Day MA | $3.85 |
| 1-Year Change | −42.53% |
| Market Cap | 245.30M |
|---|---|
| Shares Outstanding | 104.38M |
| Price to Book (P/B) | 1.93 |
| EV/EBITDA | -0.86 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Larimar Therapeutics at a Glance
As of the Oct 23, 2026 close, Larimar Therapeutics (LRMR) has a market capitalization of $245.30M.
As of its latest reported balance sheet, it holds $92.69M in cash and securities against $4.96M of debt, a net cash position of $87.73M.
Larimar Therapeutics does not currently pay a dividend.
The share price is down 42.5% over the past year. At $2.35 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $1.92 to $6.42, below its 200-day moving average of $3.85.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $16.33, 594.9% above the Oct 23, 2026 close.
Frequently Asked Questions About Larimar Therapeutics
What is the current stock price for LRMR?
As of the Oct 23, 2026 close, LRMR stock trades at $2.35. The 52-week range is $1.92–$6.42, with a day range of $2.22–$2.37.
What is the P/E ratio for LRMR?
The P/E ratio (Price-to-Earnings) for LRMR is shown in the Key Statistics section. This valuation metric helps compare Larimar Therapeutics, Inc. to industry peers.
Does LRMR pay dividends?
Larimar Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for LRMR?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for LRMR is Buy. The average 12-month price target is $16.33, a 594.9% upside from the Oct 23, 2026 close of $2.35.
What is the market cap of LRMR?
As of the Oct 23, 2026 close, Larimar Therapeutics's market capitalization is $245.3M, classifying it as a micro-cap company. Larimar Therapeutics operates in the Healthcare sector within the Biotechnology industry.